Your session is about to expire
← Back to Search
Behavioral Intervention
Digital Support for Bone Marrow Transplant
N/A
Waitlist Available
Led By Victor Wang, MS
Research Sponsored by care.coach corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Not fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 20 (d+20) post-transplant, day 90 (d+90) post-transplant
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to test how effective the care.coach Avatar™ is in helping patients undergoing outpatient transplants to reduce anxiety and improve their quality of life. The study will compare the digital intervention program with
Who is the study for?
This trial is for patients undergoing outpatient bone marrow transplant (allogeneic hematopoietic stem cell transplantation) who are interested in a digital support program to potentially improve their anxiety and quality of life during the process.
What is being tested?
The study is testing the care.coach Avatar™, a digital intervention designed to provide supportive care. It will be compared with usual supportive care programs to see if it can better help reduce anxiety and enhance quality of life for outpatient HCT recipients.
What are the potential side effects?
Since this trial involves a non-medical intervention (digital support), traditional side effects associated with medications are not expected. However, participants may experience discomfort or dissatisfaction with the technology.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not fluent in English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 20 (d+20) post-transplant, day 90 (d+90) post-transplant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 20 (d+20) post-transplant, day 90 (d+90) post-transplant
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
FACT-BMT
HADS-A
Other study objectives
Conversions
HADS-D
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: care.coach Avatar™Experimental Treatment1 Intervention
care.coach Avatar™ with usual supportive care. The avatar program includes companionship, HCT educational modules, relaxation and mindfulness exercises, simple (seated) physical exercises, nightly check ins, and symptom self-management as needed.
Group II: Usual Supportive CareActive Control1 Intervention
Traditional supportive care comprising of a binder with HCT educational materials and regular meetings with a transplant nurse.
Find a Location
Who is running the clinical trial?
care.coach corporationLead Sponsor
Dana-Farber Cancer InstituteOTHER
1,113 Previous Clinical Trials
358,791 Total Patients Enrolled
Chantal M Kerssens, PhDStudy Directorcare.coach corporation
Victor Wang, MSPrincipal Investigatorcare.coach corporation